ArriVent BioPharma, Inc. Common Stock

NASDAQ:AVBP

Biotechnology

Healthcare
$10.90 +1.40%

+$0.44 today

Market cap
$563.78M
Beta
1.42
P/E (TTM)
-9.8
EPS (TTM)
-$3.22
52W Low $16.10High $33.62

Volume 2.70M

Average 0.50M

Price history

ArriVent BioPharma, Inc. Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-45.58%

Period high

$34.74

Period low

$10.69

Latest

$10.90

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 9, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
SC 13G/ANov 5, 2026Nov 5, 2026
4Nov 2, 2026Nov 2, 2026
8-KOct 26, 2026Oct 26, 2026
8-KOct 19, 2026Oct 19, 2026
SC 13GOct 13, 2026Oct 13, 2026
8-KOct 13, 2026Oct 13, 2026
SC 13D/AOct 8, 2026Oct 8, 2026
8-KOct 6, 2026Oct 6, 2026
10-QAug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026
SC 13G/AJul 27, 2026Jul 27, 2026
4Jun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026

Competitors

Who does ArriVent BioPharma, Inc. Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about AVBP's filings, answered from its disclosures.

What is the latest AVBP filing?

The latest filing shown is 8-K dated Nov 9, 2026.

How many recent filings does AVBP have?

Intrinsic Alpha currently shows 20 recent filings for AVBP.